Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Ono Pharmaceutical - 21 Year Stock Price History | OPHLF

Historical daily share price chart and data for Ono Pharmaceutical since 2004 adjusted for splits and dividends. The latest closing stock price for Ono Pharmaceutical as of May 21, 2025 is 10.38.
  • The all-time high Ono Pharmaceutical stock closing price was 36.09 on April 25, 2016.
  • The Ono Pharmaceutical 52-week high stock price is 16.05, which is 54.6% above the current share price.
  • The Ono Pharmaceutical 52-week low stock price is 9.20, which is 11.4% below the current share price.
  • The average Ono Pharmaceutical stock price for the last 52 weeks is 12.00.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
Ono Pharmaceutical Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 10.4900 10.5437 12.7490 8.9680 10.3780 11.14%
2024 12.7609 15.5180 15.5180 8.9777 9.3376 -42.77%
2023 17.5852 18.5437 19.9547 15.3704 16.3161 -20.39%
2022 21.3526 21.3475 24.2759 20.1287 20.4952 -5.58%
2021 20.7420 24.6344 25.2291 17.8358 21.7073 -11.88%
2020 24.0248 18.3452 26.3334 15.0097 24.6344 60.75%
2019 14.9415 15.2475 15.3250 14.2585 15.3250 -34.79%
2018 21.0621 20.3208 23.4996 18.7375 23.4996 31.44%
2017 17.4815 16.2125 18.5611 16.2125 17.8782 -11.10%
2016 27.4059 26.6562 36.0908 19.8346 20.1114 -24.99%
2015 20.0097 15.9051 26.8103 15.9051 26.8103 108.64%
2014 13.5796 13.3000 14.4133 12.8502 12.8502 6.56%
2013 9.3786 7.6652 12.0596 7.6434 12.0596 52.43%
2012 8.4321 7.6425 9.0456 7.6425 7.9115 16.59%
2011 7.0969 6.1942 8.1302 6.1942 6.7856 9.90%
2010 5.8127 5.8276 6.1742 5.2856 6.1742 -6.91%
2009 5.7714 5.3108 6.6324 5.3108 6.6324 20.84%
2008 5.9478 5.6840 6.5999 5.4884 5.4884 0.19%
2007 6.1436 6.5358 6.5358 5.4778 5.4778 -0.69%
2006 5.3280 5.1885 5.5987 4.8820 5.5161 7.49%
2005 5.3676 5.7551 5.8243 4.8139 5.1318 -4.07%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $4.875B $3.197B
Ono Pharmaceuticals produces, purchases and sells pharmaceuticals and diagnostic reagents focusing primarily on prescription pharmaceuticals.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $83.493B 31.32
Zoetis (ZTS) United States $71.874B 26.82
Daiichi Sankyo, - (DSNKY) Japan $49.349B 25.11
Takeda Pharmaceutical (TAK) Japan $45.565B 9.06
Sandoz Group AG (SDZNY) Switzerland $21.424B 0.00
Summit Therapeutics (SMMT) United States $18.871B 0.00
Merck (MKKGY) Germany $17.157B 12.57
United Therapeutics (UTHR) United States $13.969B 12.36
Shionogi (SGIOY) Japan $13.560B 13.59
Neurocrine Biosciences (NBIX) United States $11.931B 40.87
IPSEN (IPSEY) France $9.964B 0.00
Orion OYJ (ORINY) Finland $8.979B 24.28
Corcept Therapeutics (CORT) United States $8.038B 65.35
Stevanato Group S.p.A (STVN) Italy $7.265B 44.43
Madrigal Pharmaceuticals (MDGL) United States $6.156B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Grifols, S.A (GRFS) Spain $5.631B 0.00
Ionis Pharmaceuticals (IONS) United States $5.332B 0.00
Soleno Therapeutics (SLNO) United States $3.694B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.966B 10.39
Crinetics Pharmaceuticals (CRNX) United States $2.804B 0.00
Hypermarcas (HYPMY) Brazil $2.702B 17.77
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.279B 12.32
BioCryst Pharmaceuticals (BCRX) United States $2.107B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.033B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.713B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.665B 0.00
Indivior (INDV) United States $1.557B 6.60
Evotec AG (EVO) Germany $1.424B 0.00
ARS Pharmaceuticals (SPRY) United States $1.397B 0.00
Guardian Pharmacy Services (GRDN) United States $1.396B 0.00
Dyne Therapeutics (DYN) United States $1.337B 0.00
Ocular Therapeutix (OCUL) United States $1.163B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.127B 22.54
Harrow (HROW) United States $0.981B 0.00
Ardelyx (ARDX) United States $0.955B 0.00
Collegium Pharmaceutical (COLL) United States $0.947B 5.11
Avadel Pharmaceuticals (AVDL) Ireland $0.885B 0.00
Enliven Therapeutics (ELVN) United States $0.831B 0.00
Cronos Group (CRON) Canada $0.798B 0.00
Xeris Biopharma Holdings (XERS) United States $0.769B 0.00
Akebia Therapeutics (AKBA) United States $0.738B 0.00
AleAnna (ANNA) United States $0.680B 0.00
KalVista Pharmaceuticals (KALV) United States $0.590B 0.00
USANA Health Sciences (USNA) United States $0.554B 12.05
Regulus Therapeutics (RGLS) United States $0.548B 0.00
Xencor (XNCR) United States $0.535B 0.00
Elite Pharmaceuticals (ELTP) United States $0.534B 0.00
Bioventus (BVS) United States $0.534B 13.54
Savara (SVRA) United States $0.503B 0.00
Relay Therapeutics (RLAY) United States $0.490B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.484B 0.00
Zevra Therapeutics (ZVRA) United States $0.474B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.471B 0.00
Altimmune (ALT) United States $0.453B 0.00
CytoDyn (CYDY) United States $0.448B 0.00
Siga Technologies (SIGA) United States $0.438B 9.15
Oruka Therapeutics (ORKA) United States $0.396B 0.00
Tourmaline Bio (TRML) United States $0.388B 0.00
Organogenesis (ORGO) United States $0.382B 0.00
Verve Therapeutics (VERV) United States $0.377B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.374B 10.12
Heron Therapeutics (HRTX) United States $0.287B 0.00
Nature's Sunshine Products (NATR) United States $0.266B 24.52
ProKidney (PROK) United States $0.226B 0.00
Aquestive Therapeutics (AQST) United States $0.225B 0.00
MediWound (MDWD) Israel $0.215B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.208B 0.00
OmniAb (OABI) United States $0.175B 0.00
Avita Medical (RCEL) United States $0.172B 0.00
Nanobiotix S.A (NBTX) France $0.172B 0.00
Esperion Therapeutics (ESPR) United States $0.169B 0.00
4D Molecular Therapeutics (FDMT) United States $0.164B 0.00
Procaps Group, S.A (PROCF) Luxembourg $0.164B 0.00
Wellgistics Health (WGRX) United States $0.162B 0.00
Liminatus Pharma (LIMN) $0.160B 0.00
Journey Medical (DERM) United States $0.157B 0.00
Profound Medical (PROF) Canada $0.154B 0.00
Inhibikase Therapeutics (IKT) United States $0.146B 0.00
Aclaris Therapeutics (ACRS) United States $0.140B 0.00
Korro Bio (KRRO) United States $0.139B 0.00
Aldeyra Therapeutics (ALDX) United States $0.135B 0.00
Protara Therapeutics (TARA) United States $0.125B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.124B 0.00
Larimar Therapeutics (LRMR) United States $0.124B 0.00
Innate Pharma SA (IPHYF) France $0.122B 0.00
Lyell Immunopharma (LYEL) United States $0.121B 0.00
Nektar Therapeutics (NKTR) United States $0.118B 0.00
Achieve Life Sciences (ACHV) Canada $0.109B 0.00
VAXART, INC (VXRT) United States $0.104B 0.00
Lexeo Therapeutics (LXEO) United States $0.102B 0.00
Cassava Sciences (SAVA) United States $0.099B 0.00
OptiNose (OPTN) United States $0.097B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.095B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.091B 0.00
Fractyl Health (GUTS) United States $0.090B 0.00
Cardiol Therapeutics (CRDL) Canada $0.088B 0.00
Champions Oncology (CSBR) United States $0.083B 13.59
Galectin Therapeutics (GALT) United States $0.081B 0.00
Arch Biopartners (ACHFF) Canada $0.081B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.074B 55.11
ESSA Pharma (EPIX) Canada $0.074B 0.00
Pyxis Oncology (PYXS) United States $0.071B 0.00
Dominari Holdings (DOMH) United States $0.069B 0.00
Inotiv (NOTV) United States $0.069B 0.00
Unicycive Therapeutics (UNCY) United States $0.069B 0.00
Vivani Medical (VANI) United States $0.067B 0.00
Assertio Holdings (ASRT) United States $0.066B 0.00
Telomir Pharmaceuticals (TELO) United States $0.063B 0.00
Surrozen (SRZN) United States $0.063B 0.00
Context Therapeutics (CNTX) United States $0.062B 0.00
Metagenomi (MGX) United States $0.062B 0.00
Nutriband (NTRB) United States $0.060B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.059B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Gain Therapeutics (GANX) United States $0.054B 0.00
Prelude Therapeutics (PRLD) United States $0.052B 0.00
Century Therapeutics (IPSC) United States $0.050B 0.00
Mural Oncology (MURA) Ireland $0.048B 0.00
PMV Pharmaceuticals (PMVP) United States $0.047B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.046B 0.00
NRx Pharmaceuticals (NRXP) United States $0.045B 0.00
Avalo Therapeutics (AVTX) United States $0.041B 0.00
Karyopharm Therapeutics (KPTI) United States $0.041B 0.00
Iterum Therapeutics (ITRM) Ireland $0.037B 0.00
ElectroCore (ECOR) United States $0.037B 0.00
Acrivon Therapeutics (ACRV) United States $0.036B 0.00
FibroGen (FGEN) United States $0.034B 0.00
Rafael Holdings (RFL) United States $0.033B 0.00
SCYNEXIS (SCYX) United States $0.030B 0.00
PolyPid (PYPD) Israel $0.029B 0.00
CASI Pharmaceuticals (CASI) China $0.024B 0.00
Tempest Therapeutics (TPST) United States $0.023B 0.00
Enlivex Therapeutics (ENLV) Israel $0.023B 0.00
Natural Alternatives (NAII) United States $0.020B 0.00
Mannatech (MTEX) United States $0.020B 0.00
Lipocine (LPCN) United States $0.019B 0.00
BioVie (BIVI) United States $0.019B 0.00
Jupiter Neurosciences (JUNS) United States $0.018B 0.00
DURECT (DRRX) United States $0.018B 0.00
Relmada Therapeutics (RLMD) United States $0.017B 0.00
TherapeuticsMD (TXMD) United States $0.017B 0.00
GlycoMimetics (GLYC) United States $0.016B 0.00
VYNE Therapeutics (VYNE) United States $0.015B 0.00
Ernexa Therapeutics (ERNA) United States $0.014B 0.00
MEI Pharma (MEIP) United States $0.014B 0.00
Cosmos Health (COSM) United States $0.014B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.012B 0.00
Vivos Therapeutics (VVOS) United States $0.012B 0.00
BioLineRx (BLRX) Israel $0.012B 0.00
ProPhase Labs (PRPH) United States $0.012B 0.00
Scienture Holdings (SCNX) United States $0.012B 0.00
Talphera (TLPH) United States $0.010B 0.00
Minerva Neurosciences (NERV) United States $0.010B 1.77
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
Biomerica (BMRA) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Phio Pharmaceuticals (PHIO) United States $0.009B 0.00
Mangoceuticals (MGRX) United States $0.008B 0.00
Ainos (AIMD) United States $0.007B 0.00
Carisma Therapeutics (CARM) United States $0.007B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
Citius Pharmaceuticals (CTXR) United States $0.007B 0.00
Traws Pharma (TRAW) United States $0.007B 0.00
TransCode Therapeutics (RNAZ) United States $0.007B 0.00
Lyra Therapeutics (LYRA) United States $0.006B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.006B 0.00
Indaptus Therapeutics (INDP) United States $0.006B 0.00
Klotho Neurosciences (KLTO) United States $0.006B 0.00
Plus Therapeutics (PSTV) United States $0.006B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Aptorum Group (APM) United Kingdom $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
Alaunos Therapeutics (TCRT) United States $0.004B 0.00
Incannex Healthcare (IXHL) Australia $0.004B 0.00
PainReform (PRFX) Israel $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Conduit Pharmaceuticals (CDT) United States $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Redhill Biopharma (RDHL) Israel $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
Jaguar Animal Health (JAGX) United States $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
SHINECO (SISI) China $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.001B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.001B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Petros Pharmaceuticals (PTPI) United States $0.000B 0.00
Aditxt (ADTX) United States $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00